%PDF-1.4
%
3 0 obj
<>
endobj
154 0 obj
<>stream
application/pdf
susan
199-Vissink1.PDF
2003-05-30T11:36:49Z
QuarkXPress (tm) - [199-Vissink1.qxd]
2016-10-07T02:55:42-07:00
2016-10-07T02:55:42-07:00
Acrobat PDFWriter 4.05 for Windows NT
uuid:047d0040-1dd2-11b2-0a00-1b0927ddd400
uuid:047d0044-1dd2-11b2-0a00-af0000000000
endstream
endobj
153 0 obj
<>
endobj
5 0 obj
<>
endobj
55 0 obj
<>
endobj
82 0 obj
<>
endobj
81 0 obj
<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
85 0 obj
<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
158 0 obj
[160 0 R]
endobj
159 0 obj
<>stream
1 1 1 rg
36.48 175.56 540 570.84 re
f
BT
0 0 0 rg
/T1_0 9 Tf
-0.0766 Tc -0.28 Tw 50.4 739.92 Td
(assessment of clinical trial research of oral mucositis induced by)Tj
-0.06551 Tc 0.2155 Tw 0 -10.56 TD
(radiation or chemotherap)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.078 Tc -0.01199 Tw 109.08 0 Td
(Cancer )Tj
/T1_0 9 Tf
-0.0563 Tc 0 Tw 27.6 0 Td
(85:2103-2)Tj
-0.2175 Tc (113.)Tj
-0.07111 Tc 1.1411 Tw -150.6 -10.44 Td
(Spak CJ, Johnson G, Ekstrand J \(1994\). Caries incidence, salivary)Tj
-0.0779 Tc 1.6279 Tw 13.92 -10.56 Td
(flow rate and efficacy of fluoride gel treatment in irradiated)Tj
-0.05901 Tc 0.089 Tw 0 -10.44 TD
(patients. )Tj
/T1_1 9 Tf
-0.0677 Tc 0.1577 Tw 35.88 0 Td
(Caries Res )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 40.2 0 Td
(28:388-393.)Tj
-0.0697 Tc 0.33971 Tw -90 -10.56 Td
(Spielman AI \(1998\). Chemosensory function and dysfunction. )Tj
/T1_1 9 Tf
-0.03081 Tc 0 Tw 246.12 0 Td
(Crit)Tj
-0.0658 Tc 0.15581 Tw -232.2 -10.44 Td
(Rev Oral Biol Med )Tj
/T1_0 9 Tf
-0.08369 Tc 0 Tw 70.68 0 Td
(9:267-291.)Tj
-0.07651 Tc 1.60651 Tw -84.6 -10.56 Td
(Spijkervet FKL, van Saene HK)Tj
-0.924 Tc 0 Tw (F)Tj
-0.0537 Tc 1.4037 Tw (, Panders AK, )Tj
-1.09801 Tc 0 Tw (V)Tj
-0.06979 Tc 1.4198 Tw (ermey A, Mehta)Tj
-0.0704 Tc 0.0871 Tw 13.92 -10.44 Td
(DM \(1989\). Scoring irradiation mucositis in head and neck can)Tj
0.00301 Tc 0 Tw [-0.08889 (-)]TJ
-0.0728 Tc 0.1628 Tw 0 -10.56 TD
(cer patients. )Tj
/T1_1 9 Tf
-0.0675 Tc 0.1575 Tw 49.92 0 Td
(J Oral Pathol Med )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 68.64 0 Td
(18:167-171.)Tj
-0.0715 Tc 2.7115 Tw -132.48 -10.44 Td
(Spijkervet FKL, van Saene HK)Tj
-0.804 Tc 0 Tw (F)Tj
-0.0755 Tc 2.67349 Tw (, van Saene JJM, Panders AK,)Tj
-0.978 Tc 0 Tw 13.92 -10.56 Td
(V)Tj
-0.0701 Tc -0.0199 Tw (ermey A, Mehta DM \(1990\). Mucositis prevention by selective)Tj
-0.06239 Tc 1.8257 Tw 0 -10.44 TD
(elimination of oral flora in irradiated head and neck cancer)Tj
-0.05901 Tc 0.089 Tw 0 -10.56 TD
(patients. )Tj
/T1_1 9 Tf
-0.0675 Tc 0.1575 Tw 35.88 0 Td
(J Oral Pathol Med )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 68.64 0 Td
(19:486-489.)Tj
-0.0715 Tc 2.7115 Tw -118.44 -10.44 Td
(Spijkervet FKL, van Saene HK)Tj
-0.804 Tc 0 Tw (F)Tj
-0.0755 Tc 2.67349 Tw (, van Saene JJM, Panders AK,)Tj
-0.978 Tc 0 Tw 13.92 -10.56 Td
(V)Tj
-0.0778 Tc 0.62781 Tw (ermey A, Mehta DM,)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
-0.04919 Tc 0.6792 Tw 93.36 0 Td
(et al.)Tj
/T1_0 9 Tf
-0.0705 Tc 0.7005 Tw 20.64 0 Td
(\(1991\). Effect of selective elimina)Tj
0.00301 Tc 0 Tw [-0.14444 (-)]TJ
-0.07491 Tc 0.694 Tw -114 -10.44 Td
(tion of the oral flora on mucositis in irradiated head and neck)Tj
-0.0618 Tc 0.15179 Tw T*
(cancer patients. )Tj
/T1_1 9 Tf
-0.09331 Tc 0.1633 Tw 63.48 0 Td
(J Surg Oncol )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 49.56 0 Td
(46:167-173.)Tj
-0.07069 Tc 0.24471 Tw -126.96 -10.44 Td
(Steel GG \(2002\). Basic clinical radiobiolog)Tj
-1.164 Tc 0 Tw (y)Tj
-0.0746 Tc 0.1046 Tw (. London: Arnold.)Tj
-0.065 Tc -0.265 Tw T*
(Steelman R, Sokol J \(1986\). Quantification of trismus following irra)Tj
0.00301 Tc 0 Tw [0.2 (-)]TJ
-0.0721 Tc 0.1741 Tw 13.92 -10.44 Td
(diation of the temporomandibular joint. )Tj
/T1_1 9 Tf
-0.05701 Tc 0.16701 Tw 159.12 0 Td
(MO Dent J )Tj
/T1_0 9 Tf
-0.073 Tc 0 Tw 43.8 0 Td
(66:21-23.)Tj
-0.0685 Tc 3.0585 Tw -216.84 -10.56 Td
(Stephens LC, Schultheiss TE, Kiang Ang K, Peters LJ \(1989\).)Tj
-0.0658 Tc 2.3158 Tw 13.92 -10.44 Td
(Pathogenesis of radiation injury to the salivary glands and)Tj
-0.07179 Tc 0.1618 Tw T*
(potential methods of protection. )Tj
/T1_1 9 Tf
-0.08549 Tc 0.17551 Tw 128.64 0 Td
(Cancer Bull )Tj
/T1_0 9 Tf
-0.1143 Tc 0 Tw 45.36 0 Td
(41:106-114.)Tj
-0.0845 Tc 1.1088 Tw -187.92 -10.44 Td
(Taylor SE, Miller EG \(1999\). Preemptive pharmacologic interven)Tj
0.00301 Tc 0 Tw 258 0 Td
(-)Tj
-0.0706 Tc -0.16341 Tw -244.08 -10.56 Td
(tion in radiation-induced salivary dysfunction. )Tj
/T1_1 9 Tf
-0.0771 Tc -0.21291 Tw 183.96 0 Td
(Proc Soc Exp Biol)Tj
-0.05901 Tc -0.03101 Tw -183.96 -10.44 Td
(Med )Tj
/T1_0 9 Tf
-0.0717 Tc 0 Tw 18.72 0 Td
(221:14-26.)Tj
-0.0793 Tc 2.5453 Tw -32.64 -10.56 Td
(Thorn JJ, Sand Hansen H, Specht L, Bastholt L \(2000\). Osteo)Tj
0.00301 Tc 0 Tw 258 0 Td
(-)Tj
-0.07471 Tc 0.2247 Tw -244.08 -10.44 Td
(radionecrosis of the jaws: clinical characteristics and relation to)Tj
-0.06371 Tc 0.1837 Tw T*
(the field of irradiation. )Tj
/T1_1 9 Tf
-0.08749 Tc 0.17751 Tw 91.44 0 Td
(J Oral Maxillofac Surg )Tj
/T1_0 9 Tf
-0.069 Tc 0 Tw 84.84 0 Td
(58:1088-1093.)Tj
-0.0871 Tc 0.7621 Tw -190.2 -10.44 Td
(Toljanic JA, Saunders VW \(1984\). Radiation therapy and manage)Tj
0.00301 Tc 0 Tw 258 0 Td
(-)Tj
-0.0656 Tc 0.1676 Tw -244.08 -10.56 Td
(ment of the irradiated patient. )Tj
/T1_1 9 Tf
-0.0764 Tc 0.1864 Tw 120.84 0 Td
(J Prosthet Dent )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 58.2 0 Td
(52:852-858.)Tj
-0.21851 Tc -0.1115 Tw -192.96 -10.44 Td
(Tomita )Tj
-1.08299 Tc 0 Tw (Y)Tj
-0.0737 Tc -0.09129 Tw (, Osaki T \(1990\). Gustatory impairment and salivary gland)Tj
-0.0704 Tc 0.3918 Tw 13.92 -10.56 Td
(pathophysiology in relation to oral cancer treatment. )Tj
/T1_1 9 Tf
-0.0495 Tc 0.4395 Tw 211.2 0 Td
(Int J Oral)Tj
-0.0789 Tc 0.1089 Tw -211.2 -10.44 Td
(Maxillofac Surg )Tj
/T1_0 9 Tf
-0.0815 Tc 0 Tw 60.36 0 Td
(19:299-304.)Tj
-0.0873 Tc 0.7719 Tw -74.28 -10.56 Td
(Tong AC, Leung AC, Cheng JC, Sham J \(1999\). Incidence of com)Tj
0.00301 Tc 0 Tw 258 0 Td
(-)Tj
-0.0721 Tc 0.14211 Tw -244.08 -10.44 Td
(plicated healing and osteoradionecrosis following tooth extrac)Tj
0.00301 Tc 0 Tw [0.06667 (-)]TJ
0.10899 Tc 3.31531 Tw T*
(tion in patients receiving radiotherapy for treatment of)Tj
-0.07339 Tc 0.10339 Tw 0 -10.44 TD
(nasopharyngeal carcinoma. )Tj
/T1_1 9 Tf
-0.069 Tc 0.13901 Tw 110.4 0 Td
(Aust Dent J )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 46.08 0 Td
(44:187-194.)Tj
-0.957 Tc -170.4 -10.56 Td
(T)Tj
-0.07359 Tc 2.2979 Tw (sujii H \(1985\). Quantitative dose-response analysis of salivary)Tj
-0.06619 Tc 1.2962 Tw 13.92 -10.44 Td
(function following radiotherapy using sequential RI-sialogra)Tj
0.00301 Tc 0 Tw [-0.16667 (-)]TJ
-0.0435 Tc 0 -10.56 TD
(ph)Tj
-1.04401 Tc (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.0737 Tc 0.2037 Tw 19.08 0 Td
(Int J Radiat Oncol Biol Phys )Tj
/T1_0 9 Tf
-0.1059 Tc 0 Tw 105.48 0 Td
(11:1603-1612.)Tj
-0.978 Tc -138.48 -10.44 Td
(V)Tj
-0.0654 Tc 1.46339 Tw (ald\351s Olmos RA, Keus RB, )Tj
-0.22 Tc 1.69 Tw (Takes R)Tj
-1.23599 Tc 0 Tw (P)Tj
-0.1244 Tc 1.4984 Tw (, Van Tinteren H, Baris G,)Tj
-0.0663 Tc 2.0163 Tw 13.92 -10.56 Td
(Hilgers FJ,)Tj
0 Tc 0.03 Tw ( )Tj
/T1_1 9 Tf
-0.0732 Tc 1.9032 Tw 47.28 0 Td
(et al.)Tj
/T1_0 9 Tf
-0.0683 Tc 1.9283 Tw 23.16 0 Td
(\(1994\). Scintigraphic assessment of salivary)Tj
-0.06931 Tc 0.49361 Tw -70.44 -10.44 Td
(function and excretion response in radiation-induced injury of)Tj
-0.06821 Tc 0.1582 Tw T*
(the major salivary glands. )Tj
/T1_1 9 Tf
-0.078 Tc 0.108 Tw 104.28 0 Td
(Cancer )Tj
/T1_0 9 Tf
-0.069 Tc 0 Tw 27.6 0 Td
(73:2886-2893.)Tj
-0.1534 Tc -0.31841 Tw -145.8 -10.44 Td
(Valdez JH, Atkinson JC, Ship JA, Fox PC \(1993\). Major salivary gland)Tj
-0.13631 Tc 2.32629 Tw 13.92 -10.56 Td
(function in patients with radiation-induced xerostomia: flow)Tj
-0.1427 Tc 0.29269 Tw 0 -10.44 TD
(rates and sialochemistr)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.21001 Tc (. )Tj
/T1_1 9 Tf
-0.1467 Tc 0.23669 Tw 97.44 0 Td
(Int J Radiat Oncol Biol Phys )Tj
/T1_0 9 Tf
-0.1263 Tc 0 Tw 103.56 0 Td
(25:41-47.)Tj
0.0773 Tc 3.3127 Tw -214.92 -10.56 Td
(Van Bokhorst-van der Schueren MAE, )Tj
0.0321 Tc 3.2979 Tw (Van Leeuwen )Tj
-0.0705 Tc 0 Tw (PAM,)Tj
-0.06 Tc 0.45 Tw 13.92 -10.44 Td
(Sauerwein H)Tj
-1.23599 Tc 0 Tw (P)Tj
-0.0688 Tc 0.4888 Tw (, Kuik DJ, Snow GB, Quak JJ \(1997\). Assessment)Tj
-0.07401 Tc 0.7973 Tw 0 -10.56 TD
(of malnutrition parameters in head and neck cancer and their)Tj
-0.0741 Tc 0.19411 Tw 0 -10.44 TD
(relation to post-operative complications. )Tj
/T1_1 9 Tf
-0.0701 Tc 0.1001 Tw 160.92 0 Td
(Head Neck )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 41.4 0 Td
(19:419-425.)Tj
-0.978 Tc -216.24 -10.56 Td
(V)Tj
-0.07201 Tc 0.2906 Tw (an Bokhorst-van der Schueren MAE, Quak JJ, )Tj
-1.09801 Tc 0 Tw (V)Tj
-0.0741 Tc 0.22411 Tw (on Blomberg-van)Tj
-0.06441 Tc 0.25439 Tw 292.92 556.56 Td
(der Flier BME, Kuik DJ, Langendoen SI, Snow GB, )Tj
/T1_1 9 Tf
-0.04919 Tc 0.3192 Tw 201.36 0 Td
(et al.)Tj
/T1_0 9 Tf
-0.0634 Tc 0 Tw 19.8 0 Td
(\(2001\).)Tj
-0.075 Tc 2.2307 Tw -221.16 -10.56 Td
(Effect of perioperative nutrition, with and without arginine)Tj
-0.0719 Tc 0.08189 Tw T*
(supplementation, on nutritional status, immune function, post)Tj
0.00301 Tc 0 Tw [0.27778 (-)]TJ
-0.0695 Tc 2.3795 Tw 0 -10.56 TD
(operative morbidit)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.07719 Tc 2.38721 Tw (, and survival in severely malnourished)Tj
-0.0654 Tc 0.1674 Tw 0 -10.44 TD
(head and neck cancer patients. )Tj
/T1_1 9 Tf
-0.0665 Tc 0.18649 Tw 123.24 0 Td
(Am J Clin Nutr )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 59.88 0 Td
(73:323-332.)Tj
-0.73801 Tc -197.04 -10.56 Td
(V)Tj
-0.1833 Tc -0.2187 Tw (issink A, Schaub RMH, van Rijn LJ, 's-Gravenmade EJ, Panders AK,)Tj
-1.09801 Tc 0 Tw 13.92 -10.44 Td
(V)Tj
-0.1776 Tc 0.2076 Tw (ermey )Tj
-0.76199 Tc 1.15199 Tw (A )Tj
-0.18469 Tc 0.5547 Tw (\(1987\). The efficacy of mucin-containing artificial sali)Tj
0.00301 Tc 0 Tw 244.08 0 Td
(-)Tj
-0.18871 Tc -0.0213 Tw -244.08 -10.56 Td
(va in alleviating symptoms of xerostomia. )Tj
/T1_1 9 Tf
-0.1913 Tc -0.01871 Tw [-0.15556 (Gerodontology )]TJ
/T1_0 9 Tf
-0.1797 Tc 0 Tw 213.96 0 Td
(6:95-101.)Tj
-0.0815 Tc 0.7972 Tw -227.88 -10.44 Td
(Vissink A, 's-Gravenmade EJ, Ligeon EE, Konings )Tj
-0.13229 Tc 0.7623 Tw (AWT \(1990\). )Tj
0.438 Tc 0 Tw (A)Tj
-0.0744 Tc -0.2556 Tw 13.92 -10.56 Td
(functional and chemical study of radiation effects on rat parotid)Tj
-0.06599 Tc 0.136 Tw T*
(and submandibular/sublingual glands. )Tj
/T1_1 9 Tf
-0.071 Tc 0.161 Tw 157.92 0 Td
(Radiat Res )Tj
/T1_0 9 Tf
-0.06979 Tc 0 Tw 41.16 0 Td
(124:259-265.)Tj
-0.0311 Tc 3.2668 Tw -213 -10.56 Td
(Vissink A, Kalicharan D, 's-Gravenmade EJ, Jongebloed WL,)Tj
-0.0672 Tc -0.3028 Tw 13.92 -10.44 Td
(Ligeon EE, Nieuwenhuis )Tj
-1.23599 Tc 0 Tw (P)Tj
-0.09 Tc (, )Tj
/T1_1 9 Tf
-0.04919 Tc -0.28081 Tw 107.4 0 Td
(et al.)Tj
/T1_0 9 Tf
-0.07159 Tc -0.4584 Tw 18.72 0 Td
(\(1991\). Acute irradiation effects)Tj
-0.06239 Tc 1.53239 Tw -126.12 -10.56 Td
(on morphology and function of rat submandibular glands.)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
0.00301 Tc 0 Tw 244.08 0 Td
(J)Tj
-0.06371 Tc 0.1337 Tw -244.08 -10.44 Td
(Oral Pathol Med )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 63.36 0 Td
(20:449-456.)Tj
-0.09309 Tc 0.8911 Tw -77.28 -10.56 Td
(Vissink A, Down JD, Konings )Tj
-0.08611 Tc 0.9561 Tw (AWT \(1992\). Contrasting dose rate)Tj
-0.0715 Tc 0.26649 Tw 13.92 -10.44 Td
(effects of gamma-irradiation on rat salivary gland function. )Tj
/T1_1 9 Tf
-0.06599 Tc 0 Tw 236.16 0 Td
(Int)Tj
-0.0627 Tc 0.13271 Tw -236.16 -10.56 Td
(J Radiat Biol )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 48 0 Td
(61:275-282.)Tj
-0.07941 Tc -0.0946 Tw -61.92 -10.44 Td
(Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP \(2003\).)Tj
-0.0753 Tc -0.2547 Tw 13.92 -10.56 Td
(Prevention and treatment of the consequences of head and neck)Tj
-0.0649 Tc 0 Tw T*
(radiotherap)Tj
-1.04401 Tc (y)Tj
-0.07491 Tc -0.1694 Tw (. Oral sequelae of head and neck radiotherap)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.03081 Tc 232.2 0 Td
(Crit)Tj
-0.0582 Tc 0.1282 Tw -232.2 -10.56 Td
(Rev Oral Med )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 54.12 0 Td
(14:213-225.)Tj
-0.0925 Tc 2.4865 Tw -68.04 -10.44 Td
(Walker R \(1975\). Direct effect of radiation on the solubility of)Tj
-0.06779 Tc 0.09779 Tw 13.92 -10.56 Td
(human teeth )Tj
/T1_1 9 Tf
-0.09171 Tc 0.2417 Tw 52.2 0 Td
(in vitro)Tj
/T1_0 9 Tf
0.03 Tc 0 Tw [0.01111 (. )]TJ
/T1_1 9 Tf
-0.0683 Tc 0.1783 Tw 31.44 0 Td
(J Dent Res )Tj
/T1_0 9 Tf
-0.0686 Tc 0 Tw 41.16 0 Td
(54:901.)Tj
-0.0891 Tc 0.2905 Tw -138.72 -10.44 Td
(Watson WJ, Scarborough JE \(1938\). Osteoradionecrosis in intraoral)Tj
-0.06419 Tc 0 Tw 13.92 -10.56 Td
(cance)Tj
-0.675 Tc (r)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.06619 Tc 0.1362 Tw 29.16 0 Td
(Am J Roentgenol )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 63.84 0 Td
(40:524-534.)Tj
-0.0825 Tc 0.1245 Tw -106.92 -10.44 Td
(Wiemann MR, Davis MK, Besic FC \(1972\). Effects of x-radiation on)Tj
-0.06599 Tc 0.216 Tw 13.92 -10.56 Td
(enamel solubilit)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.0833 Tc 0.1933 Tw 71.4 0 Td
(J Dent Res )Tj
/T1_0 9 Tf
-0.0686 Tc 0 Tw 41.16 0 Td
(51:868.)Tj
-0.0854 Tc 1.27541 Tw -126.48 -10.44 Td
(Wijers OB, Levendag PC, Harms ER, Gan-)Tj
-0.11259 Tc 1.1826 Tw (Teng AM, Schmitz PI,)Tj
-0.0605 Tc 1.77049 Tw 13.92 -10.56 Td
(Hendriks WD,)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
-0.04919 Tc 1.8792 Tw 63.12 0 Td
(et al.)Tj
/T1_0 9 Tf
-0.06709 Tc 1.8371 Tw 22.92 0 Td
(\(2001\). Mucositis reduction by selective)Tj
-0.0672 Tc 0.9012 Tw -86.04 -10.44 Td
(elimination of oral flora in irradiated cancers of the head and)Tj
-0.0699 Tc 0.4839 Tw 0 -10.56 TD
(neck: a placebo-controlled double-blind randomized stud)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.06599 Tc 236.16 0 Td
(Int)Tj
-0.0629 Tc 0.1889 Tw -236.16 -10.44 Td
(J Radiat Oncol Biol Phys )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 92.4 0 Td
(50:343-352.)Tj
-0.08459 Tc 1.75459 Tw -106.32 -10.56 Td
(Wollin M, Gilbert HA, Kagan AR \(1976\). Unequal weighting of)Tj
-0.0621 Tc 0.114 Tw 13.92 -10.44 Td
(given doses in opposed fields in treatment of cancer of the ton)Tj
0.00301 Tc 0 Tw 244.08 0 Td
(-)Tj
-0.07561 Tc 0.5256 Tw -244.08 -10.56 Td
(sillar region using 60Co, 4-, 8-, 15-, 24-Mvp photons.)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
-0.0424 Tc 0.4324 Tw 210.24 0 Td
(Med Phys)Tj
/T1_0 9 Tf
-0.015 Tc 0 Tw -210.24 -10.44 Td
(3:)Tj
-0.2059 Tc (113-116.)Tj
-0.0892 Tc 0.44321 Tw -13.92 -10.56 Td
(Wood RM, Lauder VL, Mosby EL, Hiatt WR \(1989\). Nutrition and)Tj
-0.06599 Tc 2.136 Tw 13.92 -10.44 Td
(the head and neck cancer patient.)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
-0.0731 Tc 2.1431 Tw 145.68 0 Td
(Oral Surg Oral Med Oral)Tj
-0.05499 Tc 0.08501 Tw -145.68 -10.56 Td
(Pathol )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 25.56 0 Td
(68:391-395.)Tj
-0.08121 Tc -0.0688 Tw -39.48 -10.44 Td
(Wu Q, Manning M, Schmidt-Ullrich R, Mohan R \(2000\). The poten)Tj
0.00301 Tc 0 Tw 258 0 Td
(-)Tj
-0.0744 Tc 0.6111 Tw -244.08 -10.56 Td
(tial for sparing of parotids and escalation of biologically effec)Tj
0.00301 Tc 0 Tw 244.08 0 Td
(-)Tj
-0.0661 Tc 2.91611 Tw -244.08 -10.44 Td
(tive dose with intensity-modulated radiation treatments of)Tj
-0.0739 Tc 1.2354 Tw T*
(head and neck cancers: a treatment design stud)Tj
-1.04401 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.06689 Tc 1.23689 Tw 202.92 0 Td
(Int J Radiat)Tj
-0.0605 Tc 0.1705 Tw -202.92 -10.44 Td
(Oncol Biol Phys )Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 61.08 0 Td
(46:195-205.)Tj
-0.1217 Tc 2.4317 Tw -75 -10.56 Td
(Yourassowsky E, )Tj
-0.1322 Tc 2.5222 Tw (Van der Linden M)Tj
-1.23599 Tc 0 Tw (P)Tj
-0.09171 Tc 2.4017 Tw (, Pardaens )Tj
-1.08299 Tc 0 Tw (Y)Tj
-0.076 Tc 2.446 Tw (, Crokaert )Tj
-0.927 Tc 0 Tw (F,)Tj
-0.0715 Tc 0.2215 Tw 13.92 -10.44 Td
(Glupczynski Y \(1987\). Selection and counting of aerobic Gram-)Tj
-0.0694 Tc 3.15089 Tw T*
(negative bacilli in saliva by the spiral system.)Tj
0 Tc -0.09 Tw ( )Tj
/T1_1 9 Tf
-0.06149 Tc 3.09151 Tw 203.88 0 Td
(Eur J Clin)Tj
-0.08501 Tc -0.005 Tw -203.88 -10.44 Td
(Microbiol )Tj
/T1_0 9 Tf
-0.08369 Tc 0 Tw 36.96 0 Td
(6:634-636.)Tj
-0.28 Tc -0.17 Tw -50.88 -10.56 Td
(Yusof Z)Tj
-0.96001 Tc 0 Tw (W)Tj
-0.1472 Tc -0.3028 Tw (, Bakri MM \(1993\). Severe progressive periodontal destruc)Tj
0.00301 Tc 0 Tw [0.22222 (-)]TJ
-0.1295 Tc 0.1835 Tw 13.92 -10.44 Td
(tion due to radiation tissue injur)Tj
-1.164 Tc 0 Tw (y)Tj
-0.09 Tc (. )Tj
/T1_1 9 Tf
-0.14931 Tc 0.11929 Tw 133.2 0 Td
(J Periodontol )Tj
/T1_0 9 Tf
-0.14281 Tc 0 Tw 48 0 Td
(64:1253-1258.)Tj
-0.0862 Tc 0.3082 Tw -195.12 -10.56 Td
(Zeilstra LJ, Vissink A, Konings )Tj
-0.1277 Tc 0.5177 Tw (AWT, Coppes RP \(2000\). Radiation)Tj
-0.0661 Tc 0.1561 Tw 13.92 -10.44 Td
(induced cell loss in rat submandibular gland and its relation to)Tj
-0.06239 Tc 0.1524 Tw T*
(gland function. )Tj
/T1_1 9 Tf
-0.0634 Tc 0.21339 Tw 62.4 0 Td
(Int J Radiat Biol)Tj
/T1_0 9 Tf
-0.0706 Tc 0 Tw 61.08 0 Td
(76:419-429.)Tj
ET
1 1 1 rg
36.48 26.4 540 22.56 re
f
BT
0 0 0 rg
/T1_2 11.04 Tf
-0.08 Tc 36.48 40.92 Td
(212)Tj
/T1_3 9 Tf
-0.01131 Tc 0.2513 Tw 229.56 0 Td
(Crit Rev Oral Biol Med)Tj
-0.007 Tc 0 Tw 232.2 0 Td
(14\(3\):)Tj
-0.01801 Tc (199-212)Tj
0.01801 Tc 54.24 0 Td
(\(2003\))Tj
ET
36.72 53.64 539.76 0.48 re
f
BT
0 g
/T1_4 1 Tf
0 Tc 5 0 0 5 229.9926 27 Tm
( at University of Groningen on October 7, 2016 For personal use only. No\
other uses without permission.)Tj
0 0 1 rg
-7.66998 0 Td
(cro.sagepub.com)Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
BT
/T1_4 1 Tf
5 0 0 5 238.47258 15 Tm
(International and American Associations for Dental Research)Tj
ET
endstream
endobj
12 0 obj
<>
endobj
16 0 obj
<>
endobj
8 0 obj
<>
endobj
6 0 obj
<>
endobj
157 0 obj
<>
endobj
7 0 obj
<>
endobj
88 0 obj
<>stream
HtT{Tg!d&ag"BXy_R*h@£@!*FTX^
ZtmqV;3ܙ{c~ǜ0ǥq1IqIAIj\,T^V&r2'9'nwsB_Ɵ}4ܡl&mjM6'+H,$*2jzMP+eJ
UZQkEJEL'[*Qhu|wHB\UfZBV+rmL*yQZ%ϓ.(3JY|98aua~a80sw<'`, fb,ưp,TEb茭b+ 0!``wx>ΩM ,qtNt/vb$אD
qtr'|:+n7ibax21f⯞ez-:5JR7S&Pnz1~. g=3%eViB!_`Bj킻_h 2Y!Lv!a𗌙@1brx.#wɛĞ-{UjIve`\,àkZ$JnoWHQ a-ޑ/:@T,onRZ__WW__jz#ַs!h3aˮg#ү/"w"sIð]FaDLE0MEh5Έ
;Z^pf>nnkBi>fJrq%K6m͆w: